Best Biotechnology Stocks
Drug developers, gene therapy, mRNA platforms, diagnostics. Binary outcomes - patent + FDA risk dominate. Average ROIC negative because most pre-revenue names burn cash; the few winners compound aggressively.
Industry leader
Genmab A/S GMAB
Buffett-Fit: 70/100
What drives this industry
Biotechnology is the highest-variance industry in healthcare. Patent expirations are scheduled value destruction; FDA approvals are binary risk. The Buffett-Fit framework favours commercial-stage biotechs with sustained positive net income + clear pipeline depth - typically large-cap names rather than pre-revenue clinical-stage companies. Avoid the average; chase the winners.
Top 50 ranked by Buffett-Fit
Sorted by composite quality score - ROIC, margin stability, balance-sheet strength, growth quality. Click any ticker for the full Buffett verdict.
- 1
GMABGenmab A/S16.2B mcap
70Q - 2
HALOHalozyme Therapeutics, Inc.7.9B mcap
69Q - 3
HRMYHarmony Biosciences Holdings, Inc.1.8B mcap
67Q - 4
RPRXRoyalty Pharma plc32.1B mcap
66Q - 5
NVONovo Nordisk A/S202.0B mcap
66Q - 6
CRMDCorMedix Inc.662M mcap
63Q - 7
INCYIncyte Corporation19.3B mcap
63Q - 8
CORTCorcept Therapeutics Incorporated7.5B mcap
62Q - 9
UTHRUnited Therapeutics Corporation23.6B mcap
61Q - 10
ARGXargenx SE52.2B mcap
60Q - 11
CPRXCatalyst Pharmaceuticals, Inc.3.8B mcap
59Q - 12
ALKSAlkermes plc7.0B mcap
57Q - 13
PTCTPTC Therapeutics, Inc.6.1B mcap
57Q - 14
SLNOSoleno Therapeutics, Inc.2.8B mcap
57Q - 15
AUPHAurinia Pharmaceuticals Inc.2.0B mcap
55Q - 16
AKTSAktis Oncology, Inc.1.1B mcap
55Q - 17
EXELExelixis, Inc.12.7B mcap
54Q - 18
VRTXVertex Pharmaceuticals Incorporated113.6B mcap
54Q - 19
BMRNBioMarin Pharmaceutical Inc.11.1B mcap
54Q - 20
REGNRegeneron Pharmaceuticals, Inc.64.5B mcap
54Q - 21
TECHBio-Techne Corporation8.1B mcap
53Q - 22
TBPHTheravance Biopharma, Inc.828M mcap
53Q - 23
VCELVericel Corporation1.7B mcap
52Q - 24
LBRXLB Pharmaceuticals Inc Common Stock802M mcap
51Q - 25
ALNYAlnylam Pharmaceuticals, Inc.40.3B mcap
50Q - 26
XERSXeris Biopharma Holdings, Inc.1.1B mcap
49Q - 27
ABUSArbutus Biopharma Corporation901M mcap
49Q - 28
MDXGMiMedx Group, Inc.548M mcap
49Q - 29
TGTXTG Therapeutics, Inc.5.8B mcap
49Q - 30
VCYTVeracyte, Inc.3.7B mcap
48Q - 31
LGNDLigand Pharmaceuticals Incorporated4.6B mcap
47Q - 32
APLSApellis Pharmaceuticals, Inc.5.3B mcap
47Q - 33
LKFTGalapagos N.V. Sponsored ADR1.9B mcap
46Q - 34
ALMRAlamar Biosciences, Inc.1.4B mcap
45Q - 35
INVAInnoviva, Inc.1.6B mcap
45Q - 36
EDITEditas Medicine, Inc.531M mcap
45Q - 37
GYREGyre Therapeutics, Inc.573M mcap
44Q - 38
JAZZJazz Pharmaceuticals plc14.8B mcap
44Q - 39
BTXBlackRock Technology and Private Equity Term Trust1.1B mcap
44Q - 40
KRYSKrystal Biotech, Inc.9.1B mcap
43Q - 41
MNKDMannKind Corporation1.2B mcap
43Q - 42
TECXTectonic Therapeutic, Inc.588M mcap
43Q - 43
FOLDAmicus Therapeutics, Inc.4.5B mcap
42Q - 44
BIOABioAge Labs, Inc.769M mcap
42Q - 45
TSHATaysha Gene Therapies, Inc.1.7B mcap
41Q - 46
GLPGGalapagos N.V.1.9B mcap
41Q - 47
ADMAADMA Biologics, Inc.1.8B mcap
41Q - 48
SRPTSarepta Therapeutics, Inc.1.9B mcap
40Q - 49
BCRXBioCryst Pharmaceuticals, Inc.2.3B mcap
40Q - 50
EVMNEvommune, Inc.837M mcap
40Q
More in healthcare
View the full parent sector
See all industries + sector-level statistics + framework filters.
Related on invest-like
Key terms in this analysis
Educational framework analysis only. Not investment advice, not a recommendation, not personalized to your situation. Always do your own research.